Immunogenicity and Vaccine Efficacy of -derived Extracellular Vesicles As a Novel Vaccine Candidate

Overview

Journal Virulence

Date 2025 Jan 20

PMID 39831520

Authors

Su Hyun Park

Yun Hye Kim

Hyeon Jin Lee

Jeong Moo Han

Byoung-Joo Seo

Gyeong-Seo Park

Chonghan Kim

Young Bae Ryu

Woo Sik Kim

Affiliations

Soon will be listed here.

Abstract

(APP) is a significant pathogen in the swine industry, leading to substantial economic losses and highlighting the need for effective vaccines. This study evaluates the potential of APP-derived extracellular vesicles (APP-EVs) as a vaccine candidate compared to the commercial Coglapix vaccine. APP-EVs, isolated using tangential flow filtration (TFF) and cushioned ultracentrifugation, exhibited an average size of 105 nm and a zeta potential of -17.4 mV. These EVs demonstrated stability under external stressors, such as pH changes and enzymatic exposure and were found to contain 86 major metabolites. Additionally, APP-EVs induced dendritic cell (DC) maturation in a Toll-like receptor 4 (TLR4)-dependent manner without cytotoxicity. APP-EVs predominantly elicited Th1-mediated IgG responses in immunized mice without significant liver and kidney toxicity. Contrarily, unlike Coglapix, which induced stronger Th2-mediated responses and notable toxicity. In addition, APP-EVs triggered APP-specific Th1, Th17, and cytotoxic T lymphocyte (CTL) responses and promoted the activation of multifunctional T-cells. Notably, APP-EV immunization enhanced macrophage phagocytosis and improved survival rates in mice challenged with APP infection compared to those treated with Coglapix. These findings suggest that APP-EVs are promising vaccine candidates, capable of inducing potent APP-specific T-cell responses, particularly Th1, Th17, CTL, and multifunctional T-cells, thereby enhancing the protective immune response against APP infection.

References

Somogyi Z, Mag P, Simon R, Kerek A, Makrai L, Biksi I . Susceptibility of , and Isolated from Pigs in Hungary between 2018 and 2021. Antibiotics (Basel). 2023; 12(8). PMC: 10451952. DOI: 10.3390/antibiotics12081298. View

Bui D, Lee Y, Kuo T, Chen Z, Yang W . Novel Experimental Mouse Model to Study the Pathogenesis and Therapy of Infection. Pathogens. 2024; 13(5). PMC: 11123673. DOI: 10.3390/pathogens13050412. View

Zhao L, Ye Y, Gu L, Jian Z, Stary C, Xiong X . Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis. J Transl Med. 2021; 19(1):202. PMC: 8111782. DOI: 10.1186/s12967-021-02861-y. View

Barry M, Bleackley R . Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2002; 2(6):401-9. DOI: 10.1038/nri819. View

Chen G, Bai Y, Li Z, Wang F, Fan X, Zhou X . Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant infection by modulating antigen processing and presentation pathways. Theranostics. 2020; 10(16):7131-7149. PMC: 7330855. DOI: 10.7150/thno.44564. View

Alaniz R, Deatherage B, Lara J, Cookson B . Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol. 2007; 179(11):7692-701. DOI: 10.4049/jimmunol.179.11.7692. View

Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M . The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol. 2000; 46 Suppl:S52-61. DOI: 10.1007/pl00014051. View

Zhang Y, Liang F, Zhang D, Qi S, Liu Y . Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes. Biomed Pharmacother. 2022; 157:114046. DOI: 10.1016/j.biopha.2022.114046. View

Huang Q, Huang L, Zhao G, Liu C, Pan X, Li Z . Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway. BMC Vet Res. 2024; 20(1):204. PMC: 11100192. DOI: 10.1186/s12917-024-04055-2. View

10.

Stringer O, Li Y, Bosse J, Langford P . JMM Profile: : a major cause of lung disease in pigs but difficult to control and eradicate. J Med Microbiol. 2022; 71(3). PMC: 9176268. DOI: 10.1099/jmm.0.001483. View

11.

Mehaffy C, Kruh-Garcia N, Graham B, Jarlsberg L, Willyerd C, Borisov A . Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection. J Clin Microbiol. 2020; 58(6). PMC: 7269374. DOI: 10.1128/JCM.00393-20. View

12.

Yang Z, Gao Z, Yang Z, Zhang Y, Chen H, Yang X . Lactobacillus plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis. Pharmacol Res. 2022; 182:106332. DOI: 10.1016/j.phrs.2022.106332. View

13.

A J, S S S, K S, T S M . Extracellular vesicles in bacterial and fungal diseases - Pathogenesis to diagnostic biomarkers. Virulence. 2023; 14(1):2180934. PMC: 10012962. DOI: 10.1080/21505594.2023.2180934. View

14.

Mahanty S, Prigent A, Garraud O . Immunogenicity of infectious pathogens and vaccine antigens. BMC Immunol. 2015; 16:31. PMC: 4446803. DOI: 10.1186/s12865-015-0095-y. View

15.

Kim E, Woodruff M, Grigoryan L, Maier B, Lee S, Mandal P . Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. Elife. 2020; 9. PMC: 7314549. DOI: 10.7554/eLife.52687. View

16.

Liu C, Yazdani N, Moran C, Salomon C, Seneviratne C, Ivanovski S . Unveiling clinical applications of bacterial extracellular vesicles as natural nanomaterials in disease diagnosis and therapeutics. Acta Biomater. 2024; 180:18-45. DOI: 10.1016/j.actbio.2024.04.022. View

17.

Kim W, Zhi Y, Guo H, Byun E, Lim J, Seo H . Promotion of Cellular and Humoral Immunity against Foot-and-Mouth Disease Virus by Immunization with Virus-Like Particles Encapsulated in Monophosphoryl Lipid A and Liposomes. Vaccines (Basel). 2020; 8(4). PMC: 7712044. DOI: 10.3390/vaccines8040633. View

18.

Peregrino E, Castaneda-Casimiro J, Vazquez-Flores L, Estrada-Parra S, Wong-Baeza C, Serafin-Lopez J . The Role of Bacterial Extracellular Vesicles in the Immune Response to Pathogens, and Therapeutic Opportunities. Int J Mol Sci. 2024; 25(11). PMC: 11172497. DOI: 10.3390/ijms25116210. View

19.

Lee C, Wang C, Huang H, Lin C, Leu S, Lee Y . Ferulic Acid Induces Th1 Responses by Modulating the Function of Dendritic Cells and Ameliorates Th2-Mediated Allergic Airway Inflammation in Mice. Evid Based Complement Alternat Med. 2015; 2015:678487. PMC: 4606409. DOI: 10.1155/2015/678487. View

20.

Peng Y, Yin S, Wang M . Extracellular vesicles of bacteria as potential targets for immune interventions. Hum Vaccin Immunother. 2020; 17(3):897-903. PMC: 7993133. DOI: 10.1080/21645515.2020.1799667. View